Withaferin A and Celastrol Overwhelm Proteostasis
-
Published:2023-12-27
Issue:1
Volume:25
Page:367
-
ISSN:1422-0067
-
Container-title:International Journal of Molecular Sciences
-
language:en
-
Short-container-title:IJMS
Author:
Vilaboa Nuria12ORCID, Voellmy Richard3ORCID
Affiliation:
1. Hospital Universitario La Paz-IdiPAZ, 28046 Madrid, Spain 2. CIBER de Bioingenieria, Biomateriales y Nanomedicina, CIBER-BBN, 28046 Madrid, Spain 3. HSF Pharmaceuticals SA, 1814 La Tour-de-Peilz, Switzerland
Abstract
Withaferin A (WA) and celastrol (CEL) are major bioactive components of plants that have been widely employed in traditional medicine. The pleiotropic activities of plant preparations and the isolated compounds in vitro and in vivo have been documented in hundreds of studies. Both WA and CEL were shown to have anticancer activity. Although WA and CEL belong to different chemical classes, our synthesis of the available information suggests that the compounds share basic mechanisms of action. Both WA and CEL bind covalently to numerous proteins, causing the partial unfolding of some of these proteins and of many bystander proteins. The resulting proteotoxic stress, when excessive, leads to cell death. Both WA and CEL trigger the activation of the unfolded protein response (UPR) which, if the proteotoxic stress persists, results in apoptosis mediated by the PERK/eIF-2/ATF4/CHOP pathway or another UPR-dependent pathway. Other mechanisms of cell death may play contributory or even dominant roles depending on cell type. As shown in a proteomic study with WA, the compounds appear to function largely as electrophilic reactants, indiscriminately modifying reachable nucleophilic amino acid side chains of proteins. However, a remarkable degree of target specificity is imparted by the cellular context.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference146 articles.
1. Kumar, S., Mathew, S.O., Aharwal, R.P., Tulli, H.S., Mohan, C.D., Sethi, G., Ahn, K.-S., Sandhu, S.S., Webber, K., and Bishayee, A. (2023). Withaferin A: A pleiotropic anticancer agent from the Indian medicinal plant Withania somnifera (L.) Dunal. Pharmaceuticals, 16. 2. Sultana, T., Okla, M.K., Ahmed, M., Akhtar, N., Al-Hashimi, A., Abdelgawad, H., and Haq, I.-U. (2021). Withaferin A: From Ancient Remedy to Potential Drug Candidate. Molecules, 26. 3. Biological activities of Withania somnifera;Singh;Ann. Biol. Res.,2010 4. Withaferin A enhances radiation-induced apoptosis in Caki cells through induction of reactive oxygen species, Bcl-2 downregulation and Akt inhibition;Yang;Chem.-Biol. Interact.,2011 5. Withaferin A attenuates bleomycin-induced scleroderma by targeting FoxO3a and NF-κβ signaling: Connecting fibrosis and inflammation;Bale;Biofactors,2018
|
|